Sep 07, 2018
German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results
Aug 02, 2018
Genomic Health Announces Second Quarter 2018 Financial Results and Reports Recent Business Progress
Jul 26, 2018
Genomic Health to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 2, 2018
May 30, 2018
Genomic Health to Present at Jefferies 2018 Global Healthcare Conference
May 21, 2018
New Data Reinforce Positive Impact of the Oncotype DX® Genomic Prostate Score(TM) Test in Guiding Treatment Decisions
May 09, 2018
Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference
May 02, 2018
Genomic Health Announces First Quarter 2018 Financial Results and Reports Recent Business Progress
Apr 25, 2018
Genomic Health to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 2, 2018
Mar 30, 2018
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
Feb 26, 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX® AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Feb 22, 2018
Genomic Health to Announce Fourth Quarter and Year-End 2017 Financial Results and Host Conference Call on Thursday, March 8, 2018
Feb 05, 2018
Oncotype DX® Genomic Prostate Score(TM) Test Increases Use of Active Surveillance by 30 Percent in Low-risk Patients, Resulting in Greater Adherence to Guideline-based Care
Dec 21, 2017
Genomic Health to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 11, 2017
Genomic Health Presents New Data Demonstrating Value of Oncotype DX® to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum
Dec 06, 2017
Genomic Health Announces Research Collaboration with Janssen Pharmaceuticals to Evaluate the Oncotype DX® Genomic Prostate Score(TM) Test for Potential Drug Development
Nov 30, 2017
Genomic Health Announces Presentation of 10 Oncotype DX® Studies at the 2017 San Antonio Breast Cancer Symposium Demonstrating Test's Unique Value in Predicting Neoadjuvant Treatment Benefit and Guiding Breast Cancer Staging
Nov 28, 2017
Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests
Nov 21, 2017
Genomic Health to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 08, 2017
Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress
Nov 01, 2017
Genomic Health to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017